The study identified four different types of pain among nursing home residents.

Published Date: 02 Mar 2023

Although it is recognized that pain is common among nursing home residents, little attention has been paid to how this pain changes over time. A new study from the Regenstrief Institute and the Indiana University School of Nursing...

Read Full News

Latest News

Air Conditioning or Viruses: What’s Causing Summer Colds?

Air conditioning may affect indoor air quality and comfort, but clinicians should focus on viral transmission and heat-related illness when advising patients.

How Financial Toxicity Undermines Patient Trust

Patients hand over their lives in a single meeting. Dr Emil Lou discusses why financial strain is the single biggest threat to that fragile trust.

Ultra-Processed Foods: What Are They and Why Do We Eat Them

Dr Anne Peters discusses tips for how to reduce ultra-processed food consumption with patients.

A Simpler Way to Use Estrogen Cream to Stop Repeat UTIs

For women past menopause, rubbing estrogen cream around the urinary opening may prevent repeat UTIs just as well as inserting it into the vagina with an applicator, with less itch.

Rome V Updates Diagnosis of Gut-Brain Axis Disorders

The updated Rome V criteria broaden IBS diagnosis and emphasize multidisciplinary care, including diet and psychological support, in chronic digestive disorders.

Top US Neurology and Neurosurgery Hospitals Ranked

NYU Langone Hospitals in New York City remains the best US hospital for neurology care, says the annual US News & World Report annual ranking of best hospitals for neurology and neurosurgery.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Latest News

Air conditioning may affect indoor air quality and comfort, but clinicians should focus on viral transmission and heat-related illness when advising patients.

Patients hand over their lives in a single meeting. Dr Emil Lou discusses why financial strain is the single biggest threat to that fragile trust.

Dr Anne Peters discusses tips for how to reduce ultra-processed food consumption with patients.

For women past menopause, rubbing estrogen cream around the urinary opening may prevent repeat UTIs just as well as inserting it into the vagina with an applicator, with less itch.

The updated Rome V criteria broaden IBS diagnosis and emphasize multidisciplinary care, including diet and psychological support, in chronic digestive disorders.

NYU Langone Hospitals in New York City remains the best US hospital for neurology care, says the annual US News & World Report annual ranking of best hospitals for neurology and neurosurgery.

News All Time

Otitis Media Consults, Antibiotic Rx Rebound Post-Pandemic

Childhood otitis media consultation rates and consultations with antibiotic prescribing, which fell sharply during the COVID pandemic, have recovered post-pandemic in the UK and Netherlands.

The Promise and Perils of Alternative Cancer Clinics

One family's experience reflects a growing issue in oncology: a hope that alternative therapies can succeed where conventional medicine has fallen short, a hope that can come with big risks.

NICE Criteria Miss 95% of Under-50s at Breast Cancer Risk

Full multifactorial assessment flagged 34.8% of women who developed breast cancer within a decade, against 4.4% under current NICE criteria.

Clearance of Hepatitis B Antigen Tied to Better Outcomes

Older age, low hepatitis B virus load, and loss of hepatitis B e antigen are linked to clearance of hepatitis B surface antigen, which predicts better long-term liver outcomes.

Who Owns Medical Knowledge Now?

Doctors are no longer the only source of medical knowledge in the room, and the future may depend on who preserves the most humanity.

Why Some Teens Are Vulnerable to Substance Use Disorders

Emerging research suggests vulnerability to substance use disorders may begin before the first drink or drug. Drs Leslie A. Hulvershorn and Paola P. Mattey Mora explain why.

FDA Psychiatry Roundup: July 2026

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions.

The ‘Fourth Pillar of Cancer Care’ That’s Often Missed

Oncology has shown quitting tobacco improves outcomes. Now the field must learn how to incorporate cessation treatment alongside other cancer treatments.

Biosimilar Rituximab Matches Originator in ANCA Vasculitis

At 6 months, rituximab biosimilars show remission rates comparable to the originator in patients with granulomatosis with polyangiitis and microscopic polyangiitis, with no concerning safety signals.

Brain Health Lessons From Blue Zones

Kathrin LaFaver interviews fellow neurologist Aleksandra Pikula, who completed the Blue Zones certification from the American College of Lifestyle medicine on strategies for healthy brain aging.

Only 1 in 5 Second-Level Medicare Drug Appeals Succeed

Cancer drugs prescribed on-label but denied for coverage criteria are overturned most often on independent review, raising concerns about avoidable barriers to care.

MRI Models Predict Early HCC Recurrence After Resection

Two MRI-based models effectively predicted very early hepatocellular carcinoma recurrence among patients with single BCLC stage 0/A disease following curative resection.

Pluvicto Approved Earlier in Metastatic Prostate Cancer

FDA has approved the radioligand in early disease, but whether it's better than other options is unknown.

Can Ultraprocessed Foods Affect Kids' Activity Levels?

Preschoolers consuming more ultraprocessed foods have a greater likelihood of not meeting 24-hour movement recommendations, with greater screen time than those with lower ultraprocessed food intake.

Nearly 100,000 Young People Get MenB Vaccine in a Fortnight

More than 89,000 young people in England have had their first MenB dose in 2 weeks, with 135,000 more already booked in.
HTTP error: 503

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New imaging solution could help improve survival for patients with recurring prostate cancer

2.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

3.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

4.

Screening for prostate cancer: is it time to give up digital rectal examination?

5.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

1.

Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy

2.

Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use

3.

Uncovering the Hidden Symptoms of Parathyroid Cancer in Women

4.

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025

5.

Iron Deficiency Anemia: Challenges in Diagnosis and Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

2.

Navigating the Complexities of Ph Negative ALL - Part V

3.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

4.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

5.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot